IceCure Medical Ltd (ICCM) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.27M | -5.47M | -2.71M | -2.81M | -4.04M | -4.2M | -3.15M | -2.36M | -2.85M | -2.52M | -3.32M | -3.62M |
| Operating CF Margin % | -468.83% | -427.39% | -318.24% | -535.43% | -557.1% | -479.43% | -476.28% | -233.73% | -387.32% | -190.45% | -1014.37% | -386.66% |
| Operating CF Growth % | -5.74% | -30.31% | 14.21% | -18.96% | -41.62% | -66.73% | 4.94% | 34.78% | 2.89% | 39.05% | 0.06% | 4.28% |
| Net Income | -4.27M | -4.25M | -3.86M | -3.36M | -3.59M | -4.48M | -4.15M | -3.08M | -3.58M | -3M | -4M | -3.89M |
| Depreciation & Amortization | 69K | 71K | 73K | 62K | 89K | 82K | 83K | 82K | 84.24K | 83K | 82K | 79K |
| Stock-Based Compensation | 0 | 0 | 807K | 170K | 125K | 219K | 240K | 165K | 245K | 303K | 333K | 318K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 176K | -316.44K | 126K | -84K | 42K | 6K | -38K | 34.78K | 10.7K | -92.08K | 105K | 90K |
| Working Capital Changes | -242K | -974.88K | 148K | 405K | -707K | -23K | 711K | 436.22K | 380.56K | 185.05K | 163K | -221K |
| Change in Receivables | 57K | -239K | 18K | 178K | -79K | -81K | 185K | -48.91K | -1.98K | 160.06K | 10K | 25K |
| Change in Inventory | -21K | 80.38K | -382K | -293K | -48K | -7K | -12K | 140.23K | 162.53K | 357.23K | 105K | 177K |
| Change in Payables | 125K | -306.67K | -10K | 208K | -279K | -17K | 554K | 37.48K | 154.6K | -606.48K | 477K | -33K |
| Cash from Investing | -51K | 5.22M | -5M | -23K | -5K | -7K | 805K | -843K | 491K | 8.77M | 4.2M | 1.15M |
| Capital Expenditures | -51K | -5.77K | -3K | -22K | -6K | -5K | -32K | -6K | -27.75K | -89.19K | -77K | -72K |
| CapEx % of Revenue | 5.6% | 0.45% | 0.35% | 4.19% | 0.83% | 0.57% | 4.83% | 0.59% | 3.77% | 6.75% | 23.55% | 7.68% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -5M | -1K | 1K | -2K | 0 | -837K | 4.39K | 0 | 0 | 0 |
| Cash from Financing | 3.54M | 4.13M | 7.47M | 2.08M | 2.56M | 1.1M | 3.36M | 1.89M | 2.84M | 65.56K | 15K | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 2.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3.54M | 4.13M | 9.18M | 85K | 2.56M | 1.1M | 3.36M | 1.85M | 2.84M | 65.56K | 14.53K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -1.71M | -9.64K | 0 | 0 | 0 | 38.74K | 0 | 0 | 473 | 0 |
| Net Change in Cash | -782K | 3.93M | -412K | -657K | -1.52M | -3.11M | 1.02M | -1.31M | 433K | 6.41M | 795K | -2.56M |
| Free Cash Flow | -4.32M | -5.47M | -2.71M | -2.83M | -4.04M | -4.2M | -3.19M | -2.37M | -2.88M | -2.59M | -3.39M | -3.69M |
| FCF Margin % | -474.42% | -427.84% | -318.59% | -539.62% | -557.93% | -480% | -481.12% | -234.32% | -391.12% | -196.26% | -1037.92% | -394.34% |
| FCF Growth % | -6.85% | -30.29% | 14.98% | -19.59% | -40.45% | -61.99% | 6.16% | 35.89% | 9.63% | 38.68% | 6.17% | 10.62% |
| FCF per Share | -1.76 | -2.26 | -1.24 | -1.45 | -2.11 | -2.27 | -1.82 | -1.44 | -1.85 | -1.70 | -2.23 | -2.43 |
| FCF Conversion (FCF/Net Income) | 1.00x | 1.29x | 0.70x | 0.84x | 1.13x | 0.94x | 0.76x | 0.77x | 0.80x | 0.80x | 0.83x | 0.93x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |